Literature DB >> 25122687

Are all cancer stem cells created equal?

Xiujie Xie1, Theodoros N Teknos1, Quintin Pan2.   

Abstract

Numerous solid malignancies have been reported to contain cancer stem cells (CSCs). Distinct functional characteristics have been attributed to CSCs, and thus it is widely believed that these unique cells may have genetic and phenotypic homogeneity. Recent exciting but limited evidence, however, contradicts this tenet and supports the intriguing concept of genetic and phenotypic diversity in the CSC population. We propose that CSC heterogeneity at the inter- and intrapatient levels may be due to the cell of origin, to environmental cues, and/or to human papillomavirus infection. Additional insight into CSC heterogeneity is needed to identify actionable targets for optimal eradication of the diverse CSC subpopulations within a tumor. ©AlphaMed Press.

Entities:  

Mesh:

Year:  2014        PMID: 25122687      PMCID: PMC4181401          DOI: 10.5966/sctm.2014-0085

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  28 in total

1.  Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.

Authors:  Manchao Zhang; Bhavna Kumar; Longzhu Piao; Xiujie Xie; Alessandra Schmitt; Nicole Arradaza; Michael Cippola; Matthew Old; Amit Agrawal; Enver Ozer; David E Schuller; Theodoros N Teknos; Quintin Pan
Journal:  Cancer       Date:  2013-12-30       Impact factor: 6.860

2.  Direct reprogramming by oncogenic Ras and Myc.

Authors:  Irene Ischenko; Jizu Zhi; Ute M Moll; Alice Nemajerova; Oleksi Petrenko
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

3.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma.

Authors:  Carlo C Maley; Patricia C Galipeau; Jennifer C Finley; V Jon Wongsurawat; Xiaohong Li; Carissa A Sanchez; Thomas G Paulson; Patricia L Blount; Rosa-Ana Risques; Peter S Rabinovitch; Brian J Reid
Journal:  Nat Genet       Date:  2006-03-26       Impact factor: 38.330

4.  Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.

Authors:  Sarah Schwitalla; Alexander A Fingerle; Patrizia Cammareri; Tim Nebelsiek; Serkan I Göktuna; Paul K Ziegler; Ozge Canli; Jarom Heijmans; David J Huels; Guenievre Moreaux; Rudolf A Rupec; Markus Gerhard; Roland Schmid; Nick Barker; Hans Clevers; Roland Lang; Jens Neumann; Thomas Kirchner; Makoto M Taketo; Gijs R van den Brink; Owen J Sansom; Melek C Arkan; Florian R Greten
Journal:  Cell       Date:  2012-12-27       Impact factor: 41.582

5.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Authors:  Anoop P Patel; Itay Tirosh; John J Trombetta; Alex K Shalek; Shawn M Gillespie; Hiroaki Wakimoto; Daniel P Cahill; Brian V Nahed; William T Curry; Robert L Martuza; David N Louis; Orit Rozenblatt-Rosen; Mario L Suvà; Aviv Regev; Bradley E Bernstein
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

6.  Loss of tumor-initiating cell activity in cyclophosphamide-treated breast xenografts.

Authors:  Steven P Zielske; Aaron C Spalding; Theodore S Lawrence
Journal:  Transl Oncol       Date:  2010-06-01       Impact factor: 4.243

7.  Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity.

Authors:  Christine L Chaffer; Nemanja D Marjanovic; Tony Lee; George Bell; Celina G Kleer; Ferenc Reinhardt; Ana C D'Alessio; Richard A Young; Robert A Weinberg
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

8.  Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.

Authors:  Iduna Fichtner; Jana Rolff; Richie Soong; Jens Hoffmann; Stefanie Hammer; Anette Sommer; Michael Becker; Johannes Merk
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

9.  CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.

Authors:  Amy M McCord; Muhammad Jamal; Eli S Williams; Kevin Camphausen; Philip J Tofilon
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

10.  An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.

Authors:  H E Lee; J H Kim; Y J Kim; S Y Choi; S-W Kim; E Kang; I Y Chung; I A Kim; E J Kim; Y Choi; H S Ryu; S Y Park
Journal:  Br J Cancer       Date:  2011-05-10       Impact factor: 7.640

View more
  4 in total

1.  Cancer Stem Cells Therapeutic Target Database: The First Comprehensive Database for Therapeutic Targets of Cancer Stem Cells.

Authors:  Xiaoqing Hu; Ye Cong; Huizhe Howard Luo; Sijin Wu; Liyuan Eric Zhao; Quentin Liu; Yongliang Yang
Journal:  Stem Cells Transl Med       Date:  2016-10-11       Impact factor: 6.940

2.  Cancer Stem Cells: Plasticity Works against Therapy.

Authors:  T V Vinogradova; I P Chernov; G S Monastyrskaya; L G Kondratyeva; E D Sverdlov
Journal:  Acta Naturae       Date:  2015 Oct-Dec       Impact factor: 1.845

Review 3.  Cell Cycle Regulation of Stem Cells by MicroRNAs.

Authors:  Michelle M J Mens; Mohsen Ghanbari
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

4.  Identification and chemoresistance of cancer stem cells in HPV-negative oropharyngeal cancer.

Authors:  Mehmet Gunduz; Esra Gunduz; Shunji Tamagawa; Keisuke Enomoto; Muneki Hotomi
Journal:  Oncol Lett       Date:  2019-11-21       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.